Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
[Is cobalamin measurement overprescribed by physicians? Results of an eight-year single academic centre survey]
J-B Arlet1, A Rachas2, I Colombet2
1Service de médecine interne, hôpital Européen Georges-Pompidou, faculté de médecine Paris Descartes, Sorbonne Paris-Cité et AP-HP, 20, rue Leblanc, 75015 Paris, France.
Insights
Cobalamin (vitamin B12) blood tests doubled in hospitals despite limited clinical indications. New guidelines are needed to justify the increased use of this common inpatient assay.
Area of Science:
- Clinical Chemistry
- Laboratory Medicine
- Internal Medicine
Context:
- Cobalamin (vitamin B12) measurement is a frequent inpatient laboratory test.
- Existing clinical indications for cobalamin testing have been limited and declining.
- The study examines trends in cobalamin assay volume over an eight-year period.
Purpose:
- To retrospectively evaluate changes in the volume of cobalamin (vitamin B12) measurements in an academic medical center.
- To assess the appropriateness of increased cobalamin assay ordering in clinical practice.
Summary:
- The annual number of cobalamin assays doubled between 2005 and 2012.
- The proportion of inpatients with cobalamin levels measured increased significantly, reaching 84% in some departments.
- This increase in testing volume was not supported by new scientific evidence or expanded indications.
Impact:
- Highlights a significant rise in cobalamin (vitamin B12) testing without clear justification.
- Underscores the need for updated national and international guidelines for inpatient cobalamin assay ordering.
- Suggests potential for improved resource allocation and reduced unnecessary laboratory utilization.
Introduction:
Cobalamin (Cb) blood level is widely measured among inpatients, while relevant indications for ordering this assay in clinical practice are limited and tended to decline in the recent years. We evaluated retrospectively, in a single academic centre, changes in volume of Cb measurement in an eight-year period.
Results:
The annual number of Cb assays has doubled between 2005 and 2012, from 3049 to 6158, in the medical departments of our hospital. The proportion of patients in which Cb was measured increased to 84% in the same period. The increase was of 36% in the internal medicine department. In this department, 30% of the 1753 patients admitted in 2012 had Cb measurement.
Conclusion:
The significant changes in the volume of Cb assay in recent years are not justified by any new scientific data about new indications for ordering Cb measurement. It seems necessary to establish robust national and international guidelines for inpatient Cb measurement.
Related Concept Videos
Vitamins
Dosage Regimen: Individualization
Measurement of Bioavailability: Pharmacodynamic Methods
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug Dosing: Geriatric Patients
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
